FDA updates: Salmonella investigation in moringa leaf and gluten labelling

Published: 18-Mar-2026
Regulatory

The agency has reported a Salmonella outbreak affecting 97 people across 32 US states linked to recalled moringa leaf powder supplements, while also extending its consultation on gluten ingredient disclosure requirements in packaged foods to 22 April 2026

You need to be a subscriber to read this article.
Click here to find out more.

The US Food and Drug Administration (FDA) has issued two significant updates affecting the nutraceutical sector in recent weeks.

The agency is investigating a multistate Salmonella outbreak tied to recalled moringa leaf powder supplements, urging consumers to dispose of affected products immediately, while separately extending the comment window on proposed changes to gluten ingredient labelling rules for packaged foods.

Salmonella outbreak

Firstly, this week, the agency declared that it and the CDC are investigating an outbreak of Salmonella Typhimurium and Salmonella Newport linked to recalled dietary supplements containing moringa leaf powder.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • US Food and Drug Administration (FDA)
See more

You may also like

Regulatory

FDA releases annual report on foodborne outbreaks for 2024

Read more
The report outlines the foodborne outbreaks and adverse events the agency managed in 2024, including a significant E. coli outbreak linked to carrots, a historic outbreak of illnesses associated with cheese and a series of adverse events connected to certain chocolate bars, cones and gummies

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Turmeric supplement adulteration: 22% of products contain undeclared ingredients, study finds New research reveals more than one in five turmeric-containing dietary supplements are adulterated with synthetic curcumin, undeclared dyes or diluents—posing serious quality, safety and commercial risks for nutraceutical brands
  2. Mycotechnology's Honey Truffle Sweet Protein achieves GRAS status The sweetening ingredient is now available commercially at scale for the US market, with the company positioning it as a solution for clean-label sugar reduction
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    dsm-firmenich speaks on UK Court of Appeal ruling on patent spat with Mara Renewables dsm-firmenich has talked to Nutraceutical Business Review about the UK Court of Appeal's decision to reject an appeal from the company against a 2025 ruling on one of its patents for producing microalgal DHA oil
  4. FDA reverses stance to confirm NMN is lawful for use in dietary supplements The agency’s decision marks a major policy shift, overturning its previous exclusion of NMN and clarifying the ingredient’s place in the supplement market
  5. Gain insight into skin ageing mechanisms driving nutraceutical innovation Exploring the science of skin ageing through a nutraceutical lens at the Anti-Ageing Skin Care Conference

Upcoming event

Making Nutraceuticals

21–22 April 2026 | Conference/Exhibition | Coventry, UK See all

You may also like

Regulatory

FDA releases annual report on foodborne outbreaks for 2024

The report outlines the foodborne outbreaks and adverse events the agency managed in 2024, including a significant E. coli outbreak linked to carrots, a historic outbreak of illnesses associated with cheese and a series of adverse events connected to certain chocolate bars, cones and gummies
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Regulatory roundup for nutraceuticals: news from the US and Europe

From fresh guidance on the FDA's Food Traceability Rule, to EFSA’s rapid outbreak assessment on cereulide in infant formula and rising antimicrobial resistance, regulators in the US and EU have issued key updates with implications for the nutraceutical supply chain
Regulatory

FDA calls public meeting to explore scope of dietary supplement ingredients under DSHEA

The FDA has announced a public meeting on 27 March to gather stakeholder feedback on the definition of dietary ingredient categories, including proteins, enzymes and microbials, as it considers its next regulatory steps
Regulatory

FDA to reassess the safety of food preservative BHA

The review will assess whether BHA is safe under its current conditions of use in foods such as meats, crisps and other processed products
Regulatory

FDA eases “no artificial colours” claims and expands natural food dye options

The FDA has announced a new enforcement approach allowing “no artificial colours” claims for products free from petroleum-based dyes, alongside approving beetroot red and expanded spirulina extract use to support a shift toward naturally derived food colourings
Regulatory

Florida study finds arsenic in children's sweets

The results from the investigation generate questions for the industry about how food safety data is gathered, assessed, framed and politicised
Regulatory

FDA investigates Live it Up's Super Greens powder for Salmonella outbreak

The brand has initiated a voluntary recall of the greens powder as the regulatory body warns: do not eat, sell or serve certain Live it Up-brand Super Greens dietary supplement powder
Subscribe now